InvestorsHub Logo
Followers 12
Posts 863
Boards Moderated 0
Alias Born 09/11/2017

Re: Birdbrain Ideas post# 423491

Tuesday, 04/23/2024 4:10:57 PM

Tuesday, April 23, 2024 4:10:57 PM

Post# of 426737
You should try viewing it thru the lens of how politically popular generic drugs are in the US. There's a reason 85%+ of all Rx in this country are generic. It's by legislative design. This board views it as "poor Amarin vs. vulture generics" cause you're invested in Amarin and your pocket book has personally suffered. The rest of the country views it as "greedy brand drug maker vs. generics that help poor grandma afford for her medicine". Has been all along and the facts dont matter. The appellate court commenting on some nothing disclaimer generics could use like "Not for XYZ indication" on a label should tell you they're gonna give the generics an easy CYA out on this and not cross the skinny label provisions in HW because too many people view it as the only way to ensure cheaper drugs. Besides, the real infringement occurs at the insurance level with preferred tier coverage and mandated substitution and Amarin doesnt have the clout to bite that hand that feeds them. They tried, they settled, and nothing changed.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News